Darou Pakhsh

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Darou Pakhsh Holding Company
Type Public
Traded as TSE: DARO1
ISIN: IRO1DARO0008
Industry Pharmaceuticals
Founded 1956 (as Darou Pakhsh)
1997 (as Darou Pakhsh Holding)
Headquarters Tehran, Iran
Owners TPICO (74.5%)[1]
Website www.dpholding.com

Darou Pakhsh Holding Company (Persian: شرکت داروپخش‎) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange.

History[edit]

Initially, the plant had been designed to produce 20 dosage forms. During over 40 years of activity in pharmaceutical industry, the company has been employing many qualified pharmacists, expert chemists, & skilled technicians. Also, modern machinery installation, equipping the laboratory with new analytical instruments, taking advantage of facilities along with decades of gaining scientific knowledge has brought the company up-to-date in all its sections which conform to the latest standards.

See also[edit]

References[edit]

  1. ^ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26. 
  2. ^ a b IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008 

External links[edit]